Ritedose receives FDA approval for Tobramycin Tobramycin expands nation's largest nebulized drug portfolio. - Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the ...
Generic Tobramycin Inhalation Solution marks the first cystic fibrosis (CF) product in the Company’s portfolio ...
Mild asthma could be better treated with the recent approval of the combination of albuterol/budesonide. The recent approval of albuterol/budesonide could change the way that mild asthma is treated in ...
Ritedose Pharmaceuticals has received the Food and Drug Administration’s approval for manufacturing and distributing generic albuterol sulfate inhalation solution, 0.5% (2.5 mg/0.5 ml). "Driven by the ...
As-needed use of albuterol–budesonide has been shown to result in a significantly lower risk of severe asthma exacerbation than as-needed use of albuterol alone among patients with moderate-to-severe ...
Ritedose Pharmaceuticals, a division of The Ritedose Corporation, has secured Food and Drug Administration approval for formoterol fumarate inhalation solution (20 mcg/2 ml). “The approval further ...
CHANDLER, ARIZONA, UNITED STATES, June 27, 2024 /EINPresswire.com/ -- Medivant Healthcare, a pharmaceutical company and innovator in addressing drug shortages ...
Credit: AstraZeneca. Airsupra combines albuterol, a short-acting beta2-agonist, and budesonide, an inhaled corticosteroid. Airsupra ® (albuterol/budesonide) is now available for the as-needed ...
BENGALURU, July 7 (Reuters) - Indian drugmaker Cipla (CIPL.NS), opens new tab said on Friday its U.S. unit was recalling six batches of albuterol sulfate inhalation aerosol due to a "container defect" ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback